|
Maria Feldman has over 17 years of pharmaceutical industry experience. Ms. Feldman joined MediciNova, Inc. in 2004 as Associate Director, Regulatory Affairs and was appointed Director of Regulatory Affairs in 2005. Previously, she held positions in regulatory affairs, quality assurance, pharmaceutical development and research at Isis Pharmaceuticals, Inc. and Multiple Peptide Systems. She has a broad-range of experience, in several therapeutic areas, from formulating regulatory strategies, developing registration plans, and submitting applications to worldwide health authorities, including the FDA, Health Canadaand the EMEA. Ms. Feldman has also lectured at the University of California San Diego Adult Extension Center on Regulatory and Clinical Affairs. At her most recent position at Isis Pharmaceuticals, she was involved in the regulatory approval Vitravene. Ms. Feldman received her BA in Chemistry from St. Olaf College. | 